Jones Philip, Bottomley Matthew J, Carfí Andrea, Cecchetti Ottavia, Ferrigno Federica, Lo Surdo Paola, Ontoria Jesus M, Rowley Michael, Scarpelli Rita, Schultz-Fademrecht Carsten, Steinkühler Christian
IRBM/Merck Research Laboratories, Via Pontina km 30,600, 00040 Pomezia, Italy.
Bioorg Med Chem Lett. 2008 Jun 1;18(11):3456-61. doi: 10.1016/j.bmcl.2008.02.026. Epub 2008 Feb 14.
The identification of class II HDAC inhibitors has been hampered by lack of efficient enzyme assays, in the preceding paper two assays have been developed to improve the efficiency of these enzymes: mutating an active site histidine to tyrosine, or by the use of a trifluoroacetamide lysine substrate, allowing screening to identify class II HDAC inhibitors. Herein, 2-trifluoroacetylthiophenes have been demonstrated to inhibit class II HDACs, resulting in the development of a series of 5-(trifluoroacetyl)thiophene-2-carboxamides as novel, potent and selective class II HDAC inhibitors. X-ray crystal structures of the HDAC 4 catalytic domain with a bound inhibitor demonstrate these compounds are active site inhibitors and bind in their hydrated form.
II类组蛋白去乙酰化酶(HDAC)抑制剂的鉴定一直受到缺乏有效酶检测方法的阻碍,在前一篇论文中已开发出两种检测方法来提高这些酶的检测效率:将活性位点的组氨酸突变为酪氨酸,或使用三氟乙酰胺赖氨酸底物,从而能够通过筛选来鉴定II类HDAC抑制剂。在此,已证明2-三氟乙酰噻吩可抑制II类HDAC,从而开发出一系列5-(三氟乙酰基)噻吩-2-甲酰胺作为新型、强效且选择性的II类HDAC抑制剂。HDAC 4催化结构域与结合抑制剂的X射线晶体结构表明,这些化合物是活性位点抑制剂,并以水合形式结合。